Incidental colonic 18F-fluorodeoxyglucose uptake: Do we need colonoscopy for patients with focal uptake confined to the left-sided colon?

Digestive Diseases and Sciences

Volumn 58, Issue 1, 2013, Pages 229-235

  Lee, Changhyun ^a   Koh, Seong Joon ^a   Kim, Ji Won ^a   Lee, Kook Lae ^a   Im, Jong Pil ^a   Kim, Sang Gyun ^a   Kim, Joo Sung ^a   Jung, Hyun Chae ^a   Kim, Byeong Gwan ^a  

^a Seoul National University   (South Korea)

Author keywords

Colonic neoplasm; Colonoscopy; Positron emission tomography and computed tomography; Sigmoidoscopy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; COLON; COLON ADENOMA; COLON CANCER; COLON METASTASIS; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ABSORPTION; CASE CONTROL STUDY; COLON TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; PHOTON ABSORPTIOMETRY; RETROSPECTIVE STUDY;

ABSORPTIOMETRY, PHOTON; ABSORPTION; CASE-CONTROL STUDIES; COLON; COLONIC NEOPLASMS; COLONOSCOPY; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 84873131721     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2333-y     Document Type: Article

References (28)

1. Wang G, Lau EW, Shakher R, et al. How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT? Cancer. 2007;109:117-124.
2. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496-507.
3. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480-508.
4. Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics. 2007;27:145-159.
5. Lin M, Koo JH, Abi-Hanna D. Management of patients following detection of unsuspected colon lesions by PET imaging. Clin Gastroenterol Hepatol. 2011;9:1025-1032.
6. Kei PL, Vikram R, Yeung HW, Stroehlein JR, Macapinlac HA. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results. AJR Am J Roentgenol. 2010;194:401-406.
7. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer. 2010;116:1454-1461.
8. Gutman F, Alberini JL, Wartski M, et al. Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol. 2005;185:495-500.
9. Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758-762.
10. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45:1804-1810.
11. Lee ST, Tan T, Poon AM, et al. Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-d-glucose-avid colon lesions. Mol Imaging Biol. 2008;10:48-53.
12. Lee JC, Hartnett GF, Hughes BG. Ravi Kumar AS. The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun. 2009;30:333-337.
13. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783-787.
14. Ravizza D, Bartolomei M, Santoro L, et al. Positron emission tomography for the detection of colorectal adenomas. Dig Liver Dis. 2010;42:185-190.
15. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871-876.
16. Eom BW, Lee HJ, Yoo MW, et al. Synchronous and metachronous cancers in patients with gastric cancer. J Surg Oncol. 2008;98:106-110.
17. Fisher CS, Wachtel MS, Margenthaler JA. Outcomes for patients who develop both breast and colorectal cancer. Ann Surg Oncol. 2012;19:242-248.
18. Benson AB, Choti MA, Cohen AM, et al. NCCN practice guidelines for colorectal cancer. Oncology (Williston Park). 2000;14:203-212.
19. Singh MM, Singh E, Miller H, et al. Colorectal cancer screening in women with endometrial cancer: are we following the guidelines? J Gastrointest Cancer. 2012;43:190-195.
20. Hemandas AK, Robson NK, Hickish T, Talbot RW. Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans. Colorectal Dis. 2008;10:386-389.
21. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43:759-767.
22. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-1595.
23. Yasuda S, Fujii H, Nakahara T, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42:989-992.
24. Levin TR, Farraye FA, Schoen RE, et al. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005;54:807-813.
25. Strul H, Kariv R, Leshno M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years. Am J Gastroenterol. 2006;10:255-262.
26. Mawlawi O, Podoloff DA, Kohlmyer S, et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med. 2004;45:1734-1742.
27. Treglia G, Calcagni ML, Rufini V, et al. Clinical significance of incidental focal colorectal [(18) F]FDG uptake: our experience and a review of the literature. Colorectal Dis. 2012;14:174-180.
28. Mower WR. Evaluating bias and variability in diagnostic test reports. Ann Emerg Med. 1999;33:85-91.